A court date on an early test is coming up later in May, and that's just one of several lawsuits making their way through the system.
The U.S. Food and Drug Administration is expected to authorize Pfizer's COVID-19 vaccine for youngsters ages 12 to 15 by next week, according to a federal official and a person familiar with the process, setting up shots for many before the beginning of the next school year.
The U.S. COVID-19 vaccine program was facing a setback Tuesday, when the nation's two leading health agencies recommended a pause in the use of the Johnson & Johnson vaccine to allow their scientists investigate six cases ...
In a rare admission of the weakness of Chinese coronavirus vaccines, the country's top disease control official says their effectiveness is low and the government is considering mixing them to get a boost.
JPMorgan Chase & Co.'s Jamie Dimon published his annual letter to shareholders on Wednesday, and as usual offered a broad overview of the state of the world after a year of a global pandemic, homing in on the hardship it h...
Research suggests Dollar General and Dollar Tree could be keys to more equitable vaccine distribution.
Biden spoke with Gov. Gretchen Whitmer late Thursday about the current public health situation in her state.
Dr. Elissa Schechter-Perkins is an emergency room physician at Boston Medical Center. She's also one of the authors of a study that indicates three feet of spacing is just as safe for students as six feet of distance as lo...
New applications for U.S. unemployment benefits rose in late March, but they likely to be begin falling again soon as the economy revs up, governments loosen restrictions and companies seek to hire more workers. Initial j...
The head of the Centers for Disease Control and Prevention made an emotional plea with the American public on Monday, describing her sense of "impending doom" as she urged people not to let their guard down as COVID-19 cas...
Many people who qualify for the shots wrestle with whether they ‘deserve’ them or not. Here’s what ethicists have to say.
Nobert Bischofberger helped discover Tamiflu, a well-known antiviral flu treatment. Here's why he thinks the U.S. hasn't put enough emphasis on preventative COVID-19 therapies.
Millions of Americans are getting their COVID-19 shots every day now, but the U.S. is still going to need better treatments that can nip mild or moderate cases of COVID-19 before they become serious.
No matter what, keep talking, consumer advocates say, because mortgage troubles will likely only get worse if they’re ignored.
Some 14.5 million single-family home loans are privately owned, with no federal backing, and occupy a gray area when it comes to government programs delaying foreclosure proceedings and granting payment forbearance.
he Senate on Thursday confirmed California Attorney General Xavier Becerra as President Joe Biden's health secretary, filling a key position in the administration's coronavirus response and its ambitious push to lower drug...
The latest fund manager survey from Bank of America tells the tale of bullish investors, who no longer have COVID-19 at the top of their worry list.
Camden, a North London hamlet home to both the haves and have-nots, attempts to get back on its feet one year later.
The one-shot vaccine from Johnson & Johnson could be a game-changer, but perceptions that it is inferior must be actively dispelled
Crowds could be back at sporting events in the U.K. as soon as mid-May.
In the year since New York City went into lockdown, there's more than statistics to offer striking reminders of the ever-deepening impact of the pandemic on the city.